arrow
Back
C

Constantine S. Tam

Alfred Health

76H-index
866Paper Count
3.0WCitation Count
Published Papers 144
Publication Date
Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study
err2026-08-21
err0
errOAAI
errMichael Wang; Wojciech Jurczak; Marek Trneny; David Belada; Tomasz Wrobel; Nilanjan Ghosh; Mary-Margaret Keating; Tom van Meerten; Ruben Fernandez Alvarez; Gottfried von Keudell; Catherine Thieblemont; Frederic Peyrade; Marc Andre; Marc Hoffmann; Edith Szafer-Glusman; Jennifer Lin; James P. Dean; Jutta K. Neuenburg; Constantine S. Tam
errShare
errSave
Shortened axi-cel manufacturing drives rapid in vivo expansion and shifts the acute toxicity profile in R/R LBCL
err2026-08-18
err0
errOAAI
errBrydon Panozzo; Matthew Rubic; Jian Li; Catelyn Cashion; Nicole O’Leary; Sergio Farina; Adrian Minson; Kylie Baldwin; Mary Sartor; Teresa Marzulli; Malgorzata Gorniak; Constantine S. Tam; Simon J Harrison; David Westerman; Michael J Dickinson; Emily Blyth; Shaun Fleming; David Bishop; Mark R Dowling
errShare
errSave
Fixed-duration pirtobrutinib plus venetoclax–rituximab versus venetoclax–rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial
err2026-07-09
err0
errOAAI
errMatthew S Davids; Toby A Eyre; Jennifer A Woyach; Lindsey E Roeker; Alessandra Ferrajoli; Yucai Wang; Constantine S Tam; Wojciech Jurczak; Pier Luigi Zinzani; Martin Šimkovič; Jian-Yong Li; Francesc Bosch; Damien Roos-Weil; Paula Cramer; Anders Osterborg; Prioty Islam; Ryan Jacobs; Alan Skarbnik; Seema A Bhat; Suhyun Kang
errShare
errSave
Indirect Comparison of the Efficacy of Zanubrutinib vs Ibrutinib and Acalabrutinib in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-Up
err2026-06-11
err0
errOAAI
errMazyar Shadman; Talha Munir; Sheng Xu; Keri Yang; Leyla Mohseninejad; Grace Guthrie; Jamie Hirata; Marcus Lefebure; Rhys Williams; Constantine S. Tam
errShare
errSave
Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia
err2026-01-31
err0
PREAI
errMazyar Shadman; Asher Chanan-Khan; David Campbell; Mei Xue; Marjan Massoudi; Rhys Williams; Keri Yang; Constantine S. Tam
errShare
errSave
First-line treatment for CLL in the era of targeted therapy
err2026-01-08
err0
errOAAI
errMatthew S. Davids; Stephan Stilgenbauer; Constantine S. Tam
errShare
errSave
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
err2025-12-15
err0
errOAAI
errSasanka M. Handunnetti; Amit Khot; Piers Blombery; Kate Burbury; Philip A. Thompson; David Ritchie; Rodney J. Hicks; Glenda Burke; Rachel Koldej; Mathias Bressel; Juliana Di Iulio; David A. Westerman; Stephen Lade; Andrew W. Roberts; John F. Seymour; Constantine S. Tam; Mary Ann Anderson
errShare
errSave
Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer
err2025-10-27
err0
errOAAI
errT. Virtanen; E.M. Kwan; K. Parekh; J.V.W. Bacon; C.F. Huang; I.P.L. Yu; L. Ryyppö; C. Bernales; G. Donnellan; C. Tam; J. Sipola; J. Nikkola; G. Vandekerkhove; S.H. Tolmeijer; K. Kukkonen; null Adelia; B.J. Eigl; D. Finch; R. Gagnon; Y. Takieldeen; E. Hardy; D. Khalaf; C. Kollmannsberger; J.-M. Lavoie; C. Maurice-Dror; S. Miller; L. Nappi; K. Noonan; S. Parimi; A. Riminchan; E. Sartori-Mueller; M. Soleimani; J. Vergidis; M. Zulfiqar; A. Hansen; S. Hotte; M. Jafri; M. Kolinsky; S.D. Mukherjee; M. Ong; A.A.N. Rose; W. Tu; E. Winquist; A.M. Bergman; K. van der Zande; W. Zwart; N. Mehra; N.P. van Erp; J.L. Zhao; D. Rathkopf; C. Barbieri; D. Quigley; M. Nykter; N.A. Lack; K.N. Chi; M. Annala; A.W. Wyatt
errShare
errSave
Genomic Determinants of Response and Resistance to Pirtobrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia
errBlood
IF23.1
err2025-10-10
err0
errOAAI
errJennifer R. Brown; Bastien Nguyen; Sai Prasad Desikan; Helen Won; Shady I. Tantawy; Samuel C. McNeely; Narasimha Marella; Hetal S. Randeria; Lauren M. Hanson; Andrew Parker; Salomé Calado Botelho; Jennifer A. Woyach; Krish Patel; Constantine S. Tam; Toby A. Eyre; Chan Y. Cheah; Nirav N. Shah; Paolo Ghia; Wojciech Jurczak; Minna Balbas; Binoj Nair; Paolo Abada; Chunxiao Wang; Denise Wang; Lindsey E. Roeker; Varsha Gandhi; William G. Wierda
errShare
errSave
Expert consensus opinion on the management of hairy cell leukemia in elderly patients
err2025-10-01
err0
PREAI
errTadmor, Tamar; Demeter, Judit; Fagarasanu, Andrei; Kreitman, Robert J.; Parikh, Sameer A.; Ravandi, Farhad; Rogers, Kerry A.; Saven, Alan; Seymour, John F.; Tam, Constantine S.; Tallman, Martin S.; Tiacci, Enrico; Zenz, Thorsten; Zent, Clive S.; Wormann, Bernhard; Grever, Michael R.; Yurkovski, Ilana Levy
errShare
errSave
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas
err2025-10-01
err0
PREAI
errFasser, Daniel; Joy, Greta; Dowling, Mark R.; Bavishi, Ketan; Ovlisen, Andreas Kiesbye; Choi, Philip; P'ng, Stephanie; Filshie, Robin; Ritchie, David; Bilmon, Ian; Prince, H. Miles; Wolf, Max; Hertzberg, Mark; Chuah, Hun; El-Galaly, Tarec; Tam, Constantine; Seymour, John; Villa, Diego; Cheah, Chan Y.; Lewis, Katharine L.
errShare
errSave
Risk-Guided Disease Management To Prevent Heart Failure In Adult Cancer Survivors of Previous Cardiotoxic Cancer Treatments: Baseline Results of the REDEEM Trial
err2025-09-16
err0
PREAI
errJoshua Wong; Joel Smith; Cheng Hwee Soh; Erin Howden; Jack S Talbot; Mark Nolan; Kristyn Whitmore; Leah Wright; Ashleigh-Georgia Sherriff; Eswar Sivaraj; Greg Wheeler; Kirsty Wiltshire; Phillip Campbell; Satish Ramkumar; Constantine Tam; Thomas H Marwick
errShare
errSave
Outcomes following transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from ASPEN
err2025-09-11
err0
errOAAI
errRamón García-Sanz; Roger G. Owen; Wojciech Jurczak; Meletios A. Dimopoulos; Helen McCarthy; Gavin Cull; Stephen S. Opat; Jorge J. Castillo; Marie José Kersten; Björn E. Wahlin; Sebastian Grosicki; Radha Prathikanti; Tian Tian; Heather Allewelt; Aileen Cleary Cohen; Constantine S. Tam
errShare
errSave
Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies
err2025-08-22
err0
errOAAI
errConstantine S. Tam; Mary Ann Anderson; Martin Šimkovič; Paolo Ghia; Ian W. Flinn; Kamel Laribi; Stephen Opat; Gavin Cull; Talha Munir; Anders Österborg; Alessandra Tedeschi; Megan Wang; Andy Szeto; Heather Allewelt; Tommi Salmi; Jessica Li; Linlin Xu; Ken Wu; Remus Vezan; Mazyar Shadman; Jennifer R. Brown
errShare
errSave
Neurotoxicity associated with chimeric antigen receptor T-cell therapy
err2025-08-09
err0
errOAAI
errMiriam Wronski; Robb Wesselingh; Christina Kazzi; Nabil Seery; Katherine Ko; Jian Li; Tracie H. Tan; Ty Simpson; Cassandra Abbott; Shaun Fleming; Shafqat Inam; Constantine S. Tam; Shu Min Wong; Terence O'Brien; Anneke van der Walt; Andrew Spencer; Helmut Butzkueven; Mastura Monif
errShare
errSave
Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia
err2025-08-03
err0
errOAAI
errLewis J Williams; Connie SN Li-Wai-Suen; Alex L Garnham; Stefanie M Bader; Constantine S Tam; Ashley Whitechurch; Monica A Slavin; Marcel Doerflinger; Benjamin W Teh
errShare
errSave
CLOX and neurotox: Utility of the clock drawing task in monitoring for immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T-cell therapy
err2025-07-28
err0
errOAAI
errChristina Kazzi; Ty Simpson; Miriam Wronski; Nabil Seery; Robb Wesselingh; Tracie H. Tan; Katherine Y. Ko; Daniel J. Pearce; Cassandra Abbott; Jian Li; Sarah P. Griffith; Shu Min Wong; Michael Westworth; Shafqat Inam; Constantine S. Tam; Shaun Fleming; Anneke Van Der Walt; Terence J. O'Brien; Rubina Alpitsis; Andrew Spencer; Charles B. Malpas; Paul Sanfilippo; Mastura Monif
errShare
errSave
Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)
err2025-07-08
err0
errOAAI
errMazyar Shadman; Jennifer R. Brown; Rhys Williams; Leyla Mohseninejad; Keri Yang; Pal Rakonczai; Nicole Lamanna; Sheng Xu; Aileen Cleary Cohen; Susan M. O’Brien; Alessandra Tedeschi; Constantine S. Tam
errShare
errSave
Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL
err2025-06-26
err0
errOAAI
errRakesh Awasthi; Stephan A. Grupp; Edward R. Waldron; Gregory A. Yanik; Constantine S. Tam; Susana Rives; Joseph P. McGuirk; Michael A. Pulsipher; Ulrich Jaeger; Gary D. Myers; Peter Borchmann; Stephen J. Schuster; Heather E. Stefanski; Michael R. Bishop; Abhijit Chakraborty; Aisha Masood; André Baruchel; Edmund K. Waller
errShare
errSave
Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia
err2025-02-12
err2
errOAAI
errHeyman, Benjamin M.; Opat, Stephen S.; Wahlin, Bjorn E.; Dimopoulos, Meletios-Athanasios C.; Castillo, Jorge J.; Tedeschi, Alessandra; Tam, Constantine S.; Buske, Christian; Owen, Roger G.; Leblond, Veronique ronique; Trotman, Judith; Barnes, Gisoo; Chan, Wai Y.; Schneider, Jingjing; Allewelt, Heather; Cohen, Aileen; V. Matous, Jeffrey
errShare
errSave